How have the shares performed?
Vaccinex Inc. (VCNX) saw an uptrend of 6.36% in the recent trading with $2.34 being its most recent. The current price level -75.52% lower than the highest price of $9.56 marked by the stock while trading over the past 52-weeks, whereas it is 43.56% higher than the lowest price of $1.63 the company dropped to over past 52-weeks. The latest news story on VCNX appeared in GlobeNewswire under the title “Vaccinex to Present at the Jefferies 2021 Virtual Healthcare Conference” on May-19-21.
Squeezing the time span to 30 day period shows us the stock is currently trading -15.22% below one month high and is +18.78% above of the lowest during that time. Looking into the simple moving average, Vaccinex Inc. (VCNX)’s stock stands at a SMA-50 of $2.61 while that of 5-day is reading $2.27.
Daily rise and fall of price influence many of the traders, and in order to overcome the fluctuating effect of that and to watch the stock closely, traders focus more on stock’s 200-day moving average. At various points in trading activity, investors are more likely to be making use of that measure as a strong indicator in figuring out their support and resistance levels, and VCNX’s SMA-200 as of now is $2.89.
Do analysts rate it as a buy, sell or hold?
Irrespective of recent performance, what’s important is what the future holds. In uncertain economic times, a clear picture is difficult to get. Analysts generally have a good understanding of the market works, which gives them a leg up in making predictions. Analyst ratings are often compiled into a single score from 1 to 5. The score of 1 signifies buy or strong buy, the score of 2 signifies outperform, the score of 3 means hold, and the score of 4 indicates underperform. The simple numeric range of brokerage firm referenced at the scale of 1 to 5 reads a current average recommendation of 1.00 for the stock.
Vaccinex Inc. Earnings – What Happened With VCNX
Coming around sales and income figures, publically trading companies under normal circumstances post earnings and revenues near to average estimates by the Wall Street analysts, but those could came either above or below estimates and known as surprise factor. Vaccinex Inc. (VCNX) last released financial results for the quarter that ended 12/30/2020, posting a surprise factor of 21.60% for net revenue. During the reported three-month period, company’s sales were $850.0 million while analysts on average were estimating the same to be $0.85 million.
VCNX – Vaccinex Inc. Stock Earnings Estimates
The perspective of Vaccinex Inc. (NASDAQ:VCNX)’s current quarter earnings identifies that analysts are in consensus over the estimate of -0.37 for stock’s EPS in the current quarter. 2 analysts covering the stock at Wall Street were agreed upon that EPS consensus. Company’s EPS for the last quarter was -0.29.
Investors get the exact data about the key information of institutional ownership in a listed company through its 13F filings at the Stock Exchange Commission (SEC). The total number of common shares currently owned by the public is 25.22 million. VCNX does have institutional investors; and they hold 36.30% of the stock.
Vaccinex Inc. – Insider Activity and Holdings
Moreover, the latest SEC filings also revealed that stock came across 0 new insider purchases involving 0 shares. On the other hand, VCNX declared 0 shares have been sold in 0 insider transactions over the past three months.
As on Mar 30, 2021, Vanguard Group, Inc. (The) was the top most holder in Vaccinex Inc. (NASDAQ:VCNX) with an ownership of 0.24 million shares of the company or 0.86% of the stake worth $0.73 million. The filing also reveals Susquehanna International Group, LLP as the second largest holder in the company with a control over 0.39% of the outstanding shares. Its stake is worth $0.33 million for having 0.11 million shares in hand.
Telemetry Investments, L.L.C. also came holding a key position in the company during the recent quarter and it now holds 0.37% of the outstanding shares. With this there are now 33 institutions which have possession in VCNX’s shares.
Analyst ratings are often compiled into a single score from 1 to 5. The score of 1 signifies buy or strong buy, the score of 2 signifies outperform, the score of 3 means hold, and the score of 4 indicates underperform. The simple numeric range of brokerage firm referenced at the scale of 1 to 5 reads a current average recommendation of 1.00 for the stock.
The liquidity is a key characteristic of any stock and is the main point of focus of both short-term as well as long term investors before start trading into a stock. In recently reported quarter, current ratio recorded by Vaccinex Inc. was 0.86 while posting a debt to equity ratio of 4.25.
Technical Analysis of Vaccinex Inc. (NASDAQ:VCNX) stock
To comprehend better with the trade moves and investors’ behavior, exploring the short, medium and long term technical indicators along with average volume of a stock is an effective way to make use of. When looking into those indicators for Vaccinex Inc. (VCNX), we notice that the stock’s 20-day average volume is at 261,740 shares and 50% of short term indicators are suggesting the stock as Sell. Medium term indicators at an average of 50% are spotting the stock at Sell with its 50-day average volume of 343,368 shares. And to end, VCNX’s 100-day average volume is 3,604,096 shares with 100% of the long-term indicators pointing towards Sell for the stock.